Company
Headquarters: Calgary, AB, Canada
Employees: 1
CEO: Mr. Johnny M. Forzani
| Company | Market Cap (USD) |
|---|---|
| Abbott | $178.02 B |
| Stryker Corporation | $126.48 B |
| Boston Scientific Corporation | $112.32 B |
| Medtronic | $98.95 B |
| Edwards Lifesciences Corporation | $55.63 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Forza Innovations Inc. engages in the health-tech wearable performance business. Its products in development stage include J4 Sport, J4 X, and J4 Fitbelt, which are wearable back compression devices that could be used to relax, warmup, loosen, or relax stiff and sore muscles. The company was formerly known as Genesys Industries, Inc. and changed its name to Forza Innovations Inc. in June 2021. Forza Innovations Inc. was incorporated in 2014 and is based in Calgary, Canada.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Forza Innovations, Inc. has the following listings and related stock indices.
Stock: OTC: FORZ wb_incandescent